The Medicated Skin Care Industry encompasses a goulash of offerings, including first-aid antiseptics and ointments, cold sore treatments, medicated shampoos and conditioners, anti-rash medicines, acne-fighting products, and haemorrhoid remedies, among others. Counted as drugs, Medicated Skin Care products are specified for relieving the skin’s discomfort brought about by certain illness or some physical injury, and also for helping to prevent extra damage during the healing.
The world Medicated Skin Care Market is evolving on a never-ending basis, poised to reach EUR 4.2 billion by end-2015. The growth comes from the sprouting number of older aged people worldwide, consumers’ partiality to maintaining their skin healthy and youth looking, along with the rising quest for preventative skin care. The preeminents players of the Medicated Skin Care Market scene include, among others, Johnson & Johnson (JNJ), Obagi Medical Products, Procter & Gamble (P&G), Allergan, Neutrogena, and Stiefel Laboratories.
The research reports belonging within this Catalogue comprehensively review the Medicated Skin Care Industry. The research reports feature major market trends, growth hindrances and drivers, new products’ introductions, latest industry activity, etc. The researches provide historic and actual sales figures and projections for multiple geographical Medicated Skin Care Markets. Additionally, the profiles of top as well as niche industry participants can also be tracked down in the reports.
Publications found:
5
Sort by:
